[1]
|
倪娜, 袁宜耘, 陈秋荣, 等. 表观遗传学抗肿瘤药物的临床研究进展[J]. 世界临床药物, 2022, 43(7): 831-838.
|
[2]
|
Shi, Y., Lan, F., Matson, C., et al. (2004) Histone Demethylation Mediated by the Nuclear Amine Oxi-dase Homolog LSD1. Cell, 119, 941-953. https://doi.org/10.1016/j.cell.2004.12.012
|
[3]
|
Sorna, V., Theisen, E.R., Stephens, B., Warner, S.L., et al. (2013) High-Throughput Virtual Screening Identifies Novel N’-(1-Phenylethylidene)-Benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors. Journal of Medicinal Chemistry, 56, 9496-9508. https://doi.org/10.1021/jm400870h
|
[4]
|
Zheng, Y.C., Duan, Y.C., Ma, J.L., et al. (2013) Triazole-Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration. Journal of Medicinal Chemistry, 56, 8543-8560. https://doi.org/10.1021/jm401002r
|
[5]
|
Vianello, P., Botrugno, O.A., Cappa, A., et al. (2016) Discovery of a Nov-el Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent. Journal of Medicinal Chemistry, 59, 1501-1517.
https://doi.org/10.1021/acs.jmedchem.5b01209
|
[6]
|
Mould, D.P., Alli, C., Bremberg, U., et al. (2017) Develop-ment of (4-Cyanophenyl) Glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1. Journal of Me-dicinal Chemistry, 60, 7984-7999.
https://doi.org/10.1021/acs.jmedchem.7b00462
|
[7]
|
Ma, L.Y., Zheng, Y.C., Wang, S.Q., et al. (2015) Design, Synthesis, and Structurev—Activity Relationship of Novel LSD1 Inhibitors Based on Pyrimidine—Thiourea Hybrids as Potent, Orally Active Antitumor Agents. Journal of Medicinal Chemistry, 58, 1705-1716. https://doi.org/10.1021/acs.jmedchem.5b00037
|
[8]
|
Zheng, Y.C., Ma, J., Wang, Z., et al. (2015) A Systematic Re-view of Histone Lysine-Specific Demethylase 1 and Its Inhibitors. Medicinal Research Reviews, 35, 1032-1071. https://doi.org/10.1002/med.21350
|
[9]
|
Niwa, H., Sato, S., Hashimoto, T., Matsuno, K. and Umehara, T. (2018) Crystal Structure of LSD1 in Complex with 4-[5-(Piperidin-4-Ylmethoxy)-2-(p-Tolyl) Pyridin-3-yl] Benzonitrile. Mole-cules, 23, Article 1538.
https://doi.org/10.3390/molecules23071538
|
[10]
|
付佳, 曹宇勃, 刘飒. LSD1抑制剂抑制非小细胞肺癌A549细胞侵袭、迁移及上皮间质转化[J]. 现代肿瘤医学, 2022, 30(11): 1957-1961.
|
[11]
|
王洁, 魏谨, 汪明云. LSD1和PTEN在人卵巢癌组织中的表达及相关性[J]. 现代肿瘤医学, 2021, 29(23): 4181-4184.
|
[12]
|
Wang, M., Liu, X., Jiang, G., et al. (2015) Relationship between LSD1 Expression and E-Cadherin Expression in Prostate Cancer. Interna-tional Urology and Nephrology, 47, 485-490. https://doi.org/10.1007/s11255-015-0915-2
|
[13]
|
Paul, S., Ramalin-gam, S., Subramaniam, D., et al. (2014) Histone Demethylases in Colon Cancer. Current Colorectal Cancer Reports, 10, 417-424. https://doi.org/10.1007/s11888-014-0253-2
|
[14]
|
Wang, X., Zhang, C., Zhang, X., et al. (2020) Design, Synthesis and Biological Evaluation of Tetrahydroquinoline-Based Reversible LSD1 Inhibitors. European Journal of Medicinal Chemistry, 194, Article ID: 112243.
https://doi.org/10.1016/j.ejmech.2020.112243
|
[15]
|
Li, Z., Ding, L., Li, Z., et al. (2019) Development of the Tria-zole-Fused Pyrimidine Derivatives as Highly Potent and Reversible Inhibitors of Histone Lysine Specific Demethylase 1 (LSD1/KDM1A). Acta Pharmaceutica Sinica B, 9, 794-808. https://doi.org/10.1016/j.apsb.2019.01.001
|
[16]
|
Liu, H.M., Suo, F.Z., Li, X.B., You, Y.H., et al. (2019) Discovery and Synthesis of Novel Indole Derivatives-Containing 3-Methylenedihydrofuran-2 (3H)-One as Irreversible LSD1 Inhibitors. European Journal of Medicinal Chemistry, 175, 357-372. https://doi.org/10.1016/j.ejmech.2019.04.065
|
[17]
|
Li, Z.R., Suo, F.Z., Hu, B., et al. (2019) Identification of Osimertinib (AZD9291) as a Lysine Specific Demethylase 1 Inhibitor. Bioorganic Chemistry, 84, 164-169. https://doi.org/10.1016/j.bioorg.2018.11.018
|
[18]
|
Murray-Stewart, T., Woster, P.M. and Casero Jr, R.A. (2014) The Re-Expression of the Epigenetically Silenced E-Cadherin Gene by a Polyamine Analogue Lysine-Specific Deme-thylase-1 (LSD1) Inhibitor in Human Acute Myeloid Leukemia Cell Lines. Amino Acids, 46, 585-594. https://doi.org/10.1007/s00726-013-1485-1
|
[19]
|
Kumarasinghe, I.R. and Woster, P.M. (2014) Synthesis and Eval-uation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1. ACS Medicinal Chemistry Letters, 5, 29-33. https://doi.org/10.1021/ml4002997
|
[20]
|
Nowotarski, S.L., Pachaiyappan, B., Holshouser, S.L., et al. (2015) Structure-Activity Study for (Bis) Ureidopropyl- and (Bis) Thioureidopropyldiamine LSD1 Inhibitors with 3-5-3 and 3-6-3 Carbon Backbone Architectures. Bioorganic & Medicinal Chemistry, 23, 1601-1612. https://doi.org/10.1016/j.bmc.2015.01.049
|
[21]
|
Pachaiyappan, B. and Woster, P.M. (2014) Design of Small Mole-cule Epigenetic Modulators. Bioorganic & Medicinal Chemistry Letters, 24, 21-32. https://doi.org/10.1016/j.bmcl.2013.11.001
|
[22]
|
Huang, Y., Stewart, T.M., Wu, Y., et al. (2009) Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes. Clinical Cancer Research, 15, 7217-7228.
https://doi.org/10.1158/1078-0432.CCR-09-1293
|
[23]
|
Huang, Y., Marton, L.J., Woster, P.M. and Casero Jr, R.A. (2009) Polyamine Analogues Targeting Epigenetic Gene Regulation. Essays in Biochemistry, 46, 95-110. https://doi.org/10.1042/bse0460007
|
[24]
|
Kumarasinghe, I.R. and Woster, P.M. (2018) Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1 with Improved Potency Identified by Alanine Scanning Mutagenesis. Essays in Bio-chemistry, 148, 210-220.
https://doi.org/10.1016/j.ejmech.2018.01.098
|
[25]
|
Holshouser, S., Dunworth, M., Murray-Stewart, T., et al. (2019) Dual Inhibitors of LSD1 and Spermine Oxidase. MedChemComm, 10, 778-790. https://doi.org/10.1039/C8MD00610E
|
[26]
|
Schenk, T., Chen, W.C., Göllner, S., et al. (2012) Inhibition of the LSD1 (KDM1A) Demethylase Reactivates the All-Trans-Retinoic Acid Differentiation Pathway in Acute Myeloid Leu-kemia. Nature Medicine, 18, 605-611.
https://doi.org/10.1038/nm.2661
|
[27]
|
Zhang, X., Huang, H., Zhang, Z., et al. (2021) Design, Synthesis and Bio-logical Evaluation of Novel Benzofuran Derivatives as Potent LSD1 Inhibitors. European Journal of Medicinal Chemis-try, 220, Article ID: 113501.
https://doi.org/10.1016/j.ejmech.2021.113501
|
[28]
|
Chen, Y., Yang, Y., Wang, F., et al. (2006) Crystal Structure of Human Histone Lysine-Specific Demethylase 1 (LSD1). Proceedings of the National Academy of Sciences of the United States of America, 103, 13956-13961.
https://doi.org/10.1073/pnas.0606381103
|
[29]
|
Hansch, C., Hoekman, D. and Gao, H. (1996) Comparative QSAR: Toward a Deeper Understanding of Chemicobiological Interactions. Chemical Reviews, 96, 1045-1075. https://doi.org/10.1021/cr9400976
|
[30]
|
Funatsu, K., Miyao, T. and Arakawa, M. (2011) Systematic Generation of Chemical Structures for Rational Drug Design Based on QSAR Models. Current Computer-Aided Drug Design, 7, 1-9.
https://doi.org/10.2174/157340911793743556
|
[31]
|
Roy, K. and Kar, S. (2015) Importance of Applicability Domain of QSAR Models. In: Roy, K., Ed., Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment, IGI Global, Hershey, 32.
https://doi.org/10.4018/978-1-4666-8136-1.ch005
|
[32]
|
Belka, R. and Piwowarczyk, K. (2010) Some Aspects of Using the Hyperchem Software in Study of Ni-C Nanostructures. Proceedings of SPIE—The International Society for Optical Engineering, 7745, 376-382.
https://doi.org/10.1117/12.871985
|
[33]
|
Karelson, M., Lobanov, V.S. and Katritzky, A.R. (1996) Quan-tum-Chemical Descriptors in QSAR/QSPR Studies. Chemical Reviews, 96, 1027-1044. https://doi.org/10.1021/cr950202r
|
[34]
|
Katritzky, A.R., Sild, S., Lobanov, V. and Karelson, M. (1998) Quantitative Structure—Property Relationship (QSPR) Correlation of Glass Transition Temperatures of High Molecular Weight Polymers. Journal of Chemical Information and Modeling, 38, 300-304. https://doi.org/10.1021/ci9700687
|
[35]
|
陆昕为, 蔡之华. 一种改进的GEP方法及其在演化建模预测中的应用[J]. 计算机应用, 2005, 25(12): 2783-2786.
|
[36]
|
Parsons, R., Forrest, S. and Burks, C. (1993) Genetic Algorithms for DNA Sequence Assembly. Pro-ceedings— International Conference on Intelligent Systems for Molecular Biology, 1, 310-318.
|
[37]
|
Teodorescu, L. and Sherwood, D. (2008) High Energy Physics Event Selection with Gene Expression Programming. Computer Physics Communications, 178, 409-419. https://doi.org/10.1016/j.cpc.2007.10.003
|
[38]
|
Eftekhari, M.M. (2014) Permeabil-ity Estimation in Heterogeneous Oil Reservoirs by Multi-Gene Genetic Programming Algorithm. Journal of Petroleum Science & Engineering, 123, 210-206.
https://doi.org/10.1016/j.petrol.2014.07.035
|
[39]
|
Zhang, L., Chen, J., Gao, C., Liu, C. and Xu, K. (2018) An Effi-cient Model for Auxiliary Diagnosis of Hepatocellular Carcinoma Based on Gene Expression Programming. Medical & Biological Engineering & Computing, 56, 1771-1779.
https://doi.org/10.1007/s11517-018-1811-6
|
[40]
|
Zhong, J., Feng, L. and Ong, Y.S. (2017) Gene Expression Pro-gramming: A Survey. IEEE Computational Intelligence Magazine, 12, 54-72. https://doi.org/10.1109/MCI.2017.2708618
|
[41]
|
Stanton, D.T. and Jurs, P.C. (1990) Development and Use of Charged Partial Surface Area Structural Descriptors in Computer-Assisted Quantitative Structure-Property Relationship Studies. Analytical Chemistry, 62, 2323-2329.
https://doi.org/10.1021/ac00220a013
|
[42]
|
Csizmadia, I.G. (1976) Theory and Practice of MO Calculations on Organic Molecules. Elsevier, Amsterdam.
|